EA199900675A3 - Полиморф моногидрата зополрестата - Google Patents

Полиморф моногидрата зополрестата

Info

Publication number
EA199900675A3
EA199900675A3 EA199900675A EA199900675A EA199900675A3 EA 199900675 A3 EA199900675 A3 EA 199900675A3 EA 199900675 A EA199900675 A EA 199900675A EA 199900675 A EA199900675 A EA 199900675A EA 199900675 A3 EA199900675 A3 EA 199900675A3
Authority
EA
Eurasian Patent Office
Prior art keywords
zopolestation
polymerphonography
polymerphonography zopolestation
Prior art date
Application number
EA199900675A
Other languages
English (en)
Other versions
EA199900675A2 (ru
Inventor
Джон Фрэнсис Ламберт
Тимоти Норрис
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900675A2 publication Critical patent/EA199900675A2/ru
Publication of EA199900675A3 publication Critical patent/EA199900675A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA199900675A 1998-08-21 1999-08-20 Полиморф моногидрата зополрестата EA199900675A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (2)

Publication Number Publication Date
EA199900675A2 EA199900675A2 (ru) 2000-02-28
EA199900675A3 true EA199900675A3 (ru) 2000-06-26

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900675A EA199900675A3 (ru) 1998-08-21 1999-08-20 Полиморф моногидрата зополрестата

Country Status (31)

Country Link
US (1) US6159976A (ru)
EP (1) EP0982306A3 (ru)
JP (1) JP2000072769A (ru)
KR (1) KR20000017411A (ru)
CN (1) CN1245804A (ru)
AP (1) AP9901662A0 (ru)
AU (1) AU4453299A (ru)
BG (1) BG103674A (ru)
BR (1) BR9903873A (ru)
CA (1) CA2280590A1 (ru)
EA (1) EA199900675A3 (ru)
EE (1) EE9900385A (ru)
GT (1) GT199900137A (ru)
HR (1) HRP990259A2 (ru)
HU (1) HUP9902783A3 (ru)
ID (1) ID23307A (ru)
IL (1) IL131419A0 (ru)
IS (1) IS5155A (ru)
MA (1) MA26678A1 (ru)
NO (1) NO994027L (ru)
NZ (1) NZ337363A (ru)
OA (1) OA11150A (ru)
PA (1) PA8480601A1 (ru)
PE (1) PE20000993A1 (ru)
PL (1) PL335016A1 (ru)
SG (1) SG83147A1 (ru)
TN (1) TNSN99159A1 (ru)
TR (1) TR199901996A2 (ru)
UY (1) UY25668A1 (ru)
YU (1) YU39899A (ru)
ZA (1) ZA995297B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63796B1 (sr) 2010-07-16 2022-12-30 Univ Columbia Inhibitori aldoza reduktaze i njihova upotreba
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2014126885A1 (en) * 2013-02-13 2014-08-21 Mylari Banavara L Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
DK3757107T3 (da) 2016-06-21 2023-11-27 Univ Columbia 4-oxo-3,4-dihydrothieno[3,4-d]pyridazinforbindelser som aldosereduktasehæmmere og metoder til anvendelse deraf
CA3071114A1 (en) 2017-07-28 2019-01-31 Applied Therapeutics Inc. Compositions and methods for treating galactosemia
SG11202110590PA (en) 2019-04-01 2021-10-28 Applied Therapeutics Inc Inhibitors of aldose reductase
EP4125909A1 (en) 2020-03-31 2023-02-08 Applied Therapeutics Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
CA3176768A1 (en) 2020-05-01 2021-11-04 Shoshana SHENDELMAN Aldose reductase inhibitors for treating sorbitol dehydrogenase deficiency

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
US6127367A (en) * 1996-02-29 2000-10-03 Pfizer, Inc. Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
YU39899A (sh) 2002-12-10
JP2000072769A (ja) 2000-03-07
ZA995297B (en) 2001-02-19
SG83147A1 (en) 2001-09-18
BR9903873A (pt) 2000-09-19
NO994027D0 (no) 1999-08-20
IL131419A0 (en) 2001-01-28
HRP990259A2 (en) 2000-06-30
HU9902783D0 (en) 1999-10-28
TR199901996A2 (xx) 2000-03-21
EE9900385A (et) 2000-04-17
PE20000993A1 (es) 2000-10-04
HUP9902783A2 (hu) 2000-12-28
GT199900137A (es) 2001-02-09
CA2280590A1 (en) 2000-02-21
PA8480601A1 (es) 2000-09-29
AP9901662A0 (en) 1999-09-30
AU4453299A (en) 2000-03-09
CN1245804A (zh) 2000-03-01
US6159976A (en) 2000-12-12
HUP9902783A3 (en) 2001-01-29
ID23307A (id) 2000-04-05
KR20000017411A (ko) 2000-03-25
EP0982306A2 (en) 2000-03-01
OA11150A (en) 2003-04-16
BG103674A (en) 2000-03-31
UY25668A1 (es) 2001-08-27
EP0982306A3 (en) 2000-07-05
PL335016A1 (en) 2000-02-28
TNSN99159A1 (fr) 2005-11-10
NZ337363A (en) 2001-01-26
EA199900675A2 (ru) 2000-02-28
IS5155A (is) 2000-02-22
MA26678A1 (fr) 2004-12-20
NO994027L (no) 2000-02-22

Similar Documents

Publication Publication Date Title
DE69925401D1 (de) Tintenbehälternachfüllverfahren
ATE341990T1 (de) Sigmidoskop
NO20005051D0 (no) Adjuvantsammensetninger
NO20005960L (no) Differensialinjektor
DE69926033D1 (de) Schlüsselkodekorrelationsanordnung
DE69939653D1 (de) Erkstoff
NO993442L (no) Tauheis
FI982180A (fi) Vaihtosuuntaajajärjestely
DE69937642D1 (de) Trimaranstruktur
ATE262513T1 (de) Benzoylpyridazine
NO20005934D0 (no) Evakueringsrefuge
DE69941474D1 (de) Lichtstrahlabtastgerät
NO991547L (no) Brönnhode-gjenvinningsverktöy
FI980329A0 (fi) Optiskt telekommunikationsnaet
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE69931512D1 (de) Phasendifferenzvergrösserer
DE19842103B4 (de) Stanznietzuführung
DE69905102D1 (de) Spritzgiessmaschinensteuerung
NO981231D0 (no) Klammer
NO20012720D0 (no) Metotreksatderivater
DE29819079U1 (de) Kombuchalyophilisat
ATA126298A (de) Verpuffungsklappe
FI980559A0 (fi) Audiosummeringskoppling
DE29802605U1 (de) Etagère